General Comments / Chat, page-9531

  1. 454 Posts.
    lightbulb Created with Sketch. 200
    Honestly it’s not that hard.
    Firstly of course he can’t say what pharma think of it. Those conversations are confidential obviously. And you would (should) know that.

    As for the commercial viability I don’t see how you can’t understand it? It’s pretty simple.
    RAC weren’t about to stop all plans in hope that they could develop RC220. Imagine what shareholders would say to that?! On a maybe.

    Thankfully they were able to navigate the complex task of reformulating the drug and increasing the upside from here. So now why continue spending time and money on the old formulation now you know the new one works?!
    Honestly don’t think it could be any clearer.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.15
Change
-0.015(1.29%)
Mkt cap ! $198.9M
Open High Low Value Volume
$1.16 $1.16 $1.14 $42.18K 36.75K

Buyers (Bids)

No. Vol. Price($)
1 2468 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 16 1
View Market Depth
Last trade - 15.30pm 17/07/2025 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.